Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies
Pharmaceuticals · 28.01.2023 · 16 (2) · 197
DOI: 10.3390/ph16020197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 28.01.2023. Verfasst von Leander Corrie und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Polycystic Ovarian Syndrome (PCOS) comprises a set of symptoms that pose significant risk factors for various diseases, including type 2 diabetes, cardiovascular disease, and cancer. Effective and safe methods to treat all the pathological symptoms of PCOS are not available. The gut microbiota has been shown to play an essential role in PCOS incidence and progression. Many dietary plants, prebiotics, and probiotics have been reported to ameliorate PCOS. Gut microbiota shows its effects in PCOS via a number of mechanistic pathways including maintenance of homeostasis, regulation of lipid and blood glucose levels. The effect of gut microbiota on PCOS has been widely reported in animal models but there are only a few reports of human studies. Increasing the diversity of gut microbiota, and up-regulating PCOS ameliorating gut microbiota are some of the ways through which prebiotics, probiotics, and polyphenols work. We present a comprehensive review on polyphenols from natural origin, probiotics, and fecal microbiota therapy that may be used to treat PCOS by modifying the gut microbiota.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India.
- ARCCIM, Faculty of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia.
- University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.
- School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jaipur 302017, India.
- Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600007, India.
- Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun 248007, India.
ORCID-Profile: Leander Corrie, Sukriti Vishwas, Indu Pal Kaur, Nagavendra Kommineni, Kamal Dua, Sachin Kumar Singh
Zitieren
APA
Corrie, L., Awasthi, A., Kaur, J., Vishwas, S., Gulati, M., Kaur, I. P., Gupta, G., Kommineni, N., Dua, K., & Singh, S. K. (2023). Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies. Pharmaceuticals, 16(2), 197. https://doi.org/10.3390/ph16020197
Vancouver
Corrie L, Awasthi A, Kaur J, Vishwas S, Gulati M, Kaur IP, et al. Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies. Pharmaceuticals. 2023;16(2):197. doi:10.3390/ph16020197
BibTeX
@article{Corrie2023,
author = {Corrie, Leander and Awasthi, Ankit and Kaur, Jaskiran and Vishwas, Sukriti and Gulati, Monica and Kaur, Indu Pal and Gupta, Gaurav and Kommineni, Nagavendra and Dua, Kamal and Singh, Sachin Kumar},
title = {Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {2},
pages = {197},
doi = {10.3390/ph16020197}
}
EUVIMED